Stockscreener 앱 받기
39.21
1.48%
0.57
시간 외 거래:
39.21
전일 마감가:
$38.64
열려 있는:
$38.75
하루 거래량:
646.09K
Relative Volume:
0.62
시가총액:
$3.02B
수익:
$13.17M
순이익/손실:
$-199.06M
주가수익비율:
-14.31
EPS:
-2.74
순현금흐름:
$-156.53M
1주 성능:
+1.29%
1개월 성능:
+13.98%
6개월 성능:
+5.49%
1년 성능:
-1.61%
1일 변동 폭
$38.45
$39.55
1주일 범위
$38.12
$39.84
52주 변동 폭
$26.74
$46.00
Xenon Pharmaceuticals Inc Stock (XENE) Company Profile
명칭
Xenon Pharmaceuticals Inc
전화
(604) 484-3300
주소
200 - 3650 GILMORE WAY, BURNABY
XENE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XENE
Xenon Pharmaceuticals Inc
|
39.21 | 2.98B | 13.17M | -199.06M | -156.53M | -2.74 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Xenon Pharmaceuticals Inc Stock (XENE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-03 | 재개 | Wells Fargo | Overweight |
| 2025-05-07 | 개시 | Chardan Capital Markets | Buy |
| 2025-02-11 | 개시 | Deutsche Bank | Buy |
| 2024-10-10 | 재개 | Raymond James | Outperform |
| 2024-10-01 | 개시 | H.C. Wainwright | Buy |
| 2024-01-04 | 개시 | Citigroup | Buy |
| 2023-12-08 | 개시 | Robert W. Baird | Outperform |
| 2023-10-24 | 재개 | Cantor Fitzgerald | Overweight |
| 2023-04-25 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-12-14 | 개시 | Goldman | Buy |
| 2022-12-12 | 개시 | Cowen | Outperform |
| 2022-11-28 | 개시 | Wells Fargo | Overweight |
| 2022-10-19 | 개시 | Raymond James | Outperform |
| 2022-08-29 | 개시 | BofA Securities | Buy |
| 2022-07-21 | 개시 | JP Morgan | Overweight |
| 2021-10-28 | 개시 | RBC Capital Mkts | Outperform |
| 2020-10-02 | 개시 | SVB Leerink | Outperform |
| 2020-07-21 | 개시 | Needham | Buy |
| 2020-06-01 | 재개 | Jefferies | Buy |
| 2020-03-25 | 개시 | Wedbush | Outperform |
| 2020-01-08 | 개시 | William Blair | Outperform |
| 2019-09-20 | 개시 | Guggenheim | Buy |
| 2018-08-08 | 재확인 | Stifel | Buy |
| 2017-03-13 | 개시 | Jefferies | Buy |
| 2016-10-21 | 개시 | Stifel | Buy |
| 2016-09-26 | 개시 | Guggenheim | Buy |
| 2016-04-14 | 재확인 | Jefferies | Buy |
| 2015-10-30 | 재개 | Jefferies | Buy |
| 2014-12-02 | 개시 | Canaccord Genuity | Buy |
모두보기
Xenon Pharmaceuticals Inc 주식(XENE)의 최신 뉴스
Price momentum metrics for Xenon Pharmaceuticals Inc. explainedDividend Hike & AI Driven Stock Price Forecasts - Newser
How to build a custom watchlist for Xenon Pharmaceuticals Inc.July 2025 Update & Free Long-Term Investment Growth Plans - Newser
Can Xenon Pharmaceuticals Inc. sustain its profitabilityJuly 2025 Movers & Fast Gaining Stock Strategy Reports - خودرو بانک
What is Xenon Pharmaceuticals Inc.’s market positionMarket Risk Report & Stepwise Entry and Exit Trade Signals - خودرو بانک
Can swing trading help recover from Xenon Pharmaceuticals Inc. lossesRisk Management & Daily Risk Controlled Trade Plans - Newser
Chart based analysis of Xenon Pharmaceuticals Inc. trends2025 Breakouts & Breakdowns & Risk Controlled Stock Alerts - Newser
Understanding Xenon Pharmaceuticals Inc.’s price movementWeekly Trend Summary & Entry Point Confirmation Signals - Newser
Building trade automation scripts for Xenon Pharmaceuticals Inc.Weekly Trade Summary & Technical Pattern Based Signals - Newser
Is Xenon Pharmaceuticals Inc. a speculative investmentTrade Analysis Summary & Low Drawdown Investment Strategies - خودرو بانک
Can Xenon Pharmaceuticals Inc. deliver consistent dividendsWeekly Investment Summary & Growth Focused Entry Point Reports - خودرو بانک
Ranking Xenon Pharmaceuticals Inc. among high performing stocks via toolsJuly 2025 Technicals & Verified Momentum Stock Watchlist - Newser
How to use Fibonacci retracement on Xenon Pharmaceuticals Inc.2025 Pullback Review & Daily Stock Trend Reports - Newser
Can machine learning forecast Xenon Pharmaceuticals Inc. recoveryWeekly Earnings Recap & Low Volatility Stock Suggestions - Newser
How does Xenon Pharmaceuticals Inc. compare to its peersEarnings Trend Report & Low Risk High Win Rate Picks - خودرو بانک
Momentum divergence signals in Xenon Pharmaceuticals Inc. chartWeekly Trade Review & Long-Term Safe Investment Plans - Newser
Analyzing Xenon Pharmaceuticals Inc. with risk reward ratio chartsJuly 2025 Closing Moves & High Return Stock Watch Alerts - Newser
Price action breakdown for Xenon Pharmaceuticals Inc.July 2025 Closing Moves & Technical Pattern Based Buy Signals - Newser
Xenon (XENE) Receives a Buy from RBC Capital - The Globe and Mail
Applying Elliott Wave Theory to Xenon Pharmaceuticals Inc.2025 Retail Activity & Stepwise Trade Signal Implementation - Newser
Will Xenon Pharmaceuticals Inc. benefit from rate cutsGap Up & Low Drawdown Investment Ideas - خودرو بانک
Published on: 2025-09-03 01:33:36 - Newser
Using AI based signals to follow Xenon Pharmaceuticals Inc.CPI Data & AI Powered Buy and Sell Recommendations - Newser
Predicting Xenon Pharmaceuticals Inc. trend using moving averagesBuy Signal & Safe Capital Growth Plans - Newser
Volume Recap: Can Xenon Pharmaceuticals Inc. navigate macro headwindsQuarterly Investment Review & Real-Time Chart Breakout Alerts - خودرو بانک
Developing predictive dashboards with Xenon Pharmaceuticals Inc. dataPortfolio Performance Summary & Weekly Market Pulse Alerts - Newser
What is Xenon Pharmaceuticals Inc.’s book value per sharePortfolio Update Summary & Real-Time Volume Triggers - خودرو بانک
Xenon Pharmaceuticals shares fall 1.50% premarket after equity inducement grants to new employees. - AInvest
RBC Raises Xenon Price Target, Cites Phase III Optimism for Epilepsy Drug - MSN
Is Xenon Pharmaceuticals Inc. reversing from oversold territory2025 Trading Recap & Intraday High Probability Alerts - Newser
Using RSI to spot recovery in Xenon Pharmaceuticals Inc.Weekly Trade Review & Smart Investment Allocation Tips - Newser
Xenon Pharmaceuticals Q2 Earnings Call Highlights Strong Progress and Promising Future - AInvest
Xenon Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(4) - MarketScreener
What dividend growth rate does Xenon Pharmaceuticals Inc. offerWeekly Stock Summary & Weekly Watchlist for Hot Stocks - khodrobank.com
How to integrate Xenon Pharmaceuticals Inc. into portfolio analysis toolsTreasury Yields & Fast Exit and Entry Trade Guides - Newser
Is Xenon Pharmaceuticals Inc. stock reversal real or fakeEarnings Beat & AI Enhanced Trading Alerts - Newser
Xenon Pharmaceuticals Inc (XENE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Xenon Pharmaceuticals Inc 주식 (XENE) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| GANNON STEVEN | Director |
May 14 '25 |
Option Exercise |
12.57 |
5,144 |
64,660 |
7,144 |
| MORTIMER IAN | PRESIDENT & CEO |
Jan 24 '25 |
Option Exercise |
17.76 |
22,468 |
399,032 |
53,770 |
| MORTIMER IAN | PRESIDENT & CEO |
Jan 27 '25 |
Option Exercise |
17.76 |
16,315 |
289,754 |
46,468 |
| MORTIMER IAN | PRESIDENT & CEO |
Jan 23 '25 |
Option Exercise |
17.76 |
16,217 |
288,014 |
47,519 |
| MORTIMER IAN | PRESIDENT & CEO |
Jan 24 '25 |
Sale |
40.20 |
22,468 |
903,214 |
31,302 |
| MORTIMER IAN | PRESIDENT & CEO |
Jan 27 '25 |
Sale |
40.50 |
16,315 |
660,806 |
31,302 |
| MORTIMER IAN | PRESIDENT & CEO |
Jan 23 '25 |
Sale |
40.08 |
16,217 |
649,977 |
31,302 |
1.40%
자본화:
|
볼륨(24시간):